VIROLOGICAL BREAKTHROUGH AND GENOTYPIC RESISTANCE IN A RANDOMIZED, CONTROLLED STUDY ON TELBIVUDINE TREATMENT APPLYING ROADMAP CONCEPT IN CHB: W76 INTERIM ANALYSIS OF EFFORT STUDY
第一作者单位:[1]Nanfang Med Univ, Hepatol Unit, Guangzhou, Guangdong, Peoples R China
推荐引用方式(GB/T 7714):
Hou J.,Sun J.,Xie Q.,et al.VIROLOGICAL BREAKTHROUGH AND GENOTYPIC RESISTANCE IN A RANDOMIZED, CONTROLLED STUDY ON TELBIVUDINE TREATMENT APPLYING ROADMAP CONCEPT IN CHB: W76 INTERIM ANALYSIS OF EFFORT STUDY[J].JOURNAL OF HEPATOLOGY.2012,56:S203-S204.doi:10.1016/S0168-8278(12)60528-5.
APA:
Hou, J.,Sun, J.,Xie, Q.,Tan, D.,Ning, Q....&Zhuang, H..(2012).VIROLOGICAL BREAKTHROUGH AND GENOTYPIC RESISTANCE IN A RANDOMIZED, CONTROLLED STUDY ON TELBIVUDINE TREATMENT APPLYING ROADMAP CONCEPT IN CHB: W76 INTERIM ANALYSIS OF EFFORT STUDY.JOURNAL OF HEPATOLOGY,56,
MLA:
Hou, J.,et al."VIROLOGICAL BREAKTHROUGH AND GENOTYPIC RESISTANCE IN A RANDOMIZED, CONTROLLED STUDY ON TELBIVUDINE TREATMENT APPLYING ROADMAP CONCEPT IN CHB: W76 INTERIM ANALYSIS OF EFFORT STUDY".JOURNAL OF HEPATOLOGY 56.(2012):S203-S204